"Etablissement de santé privé d’intérêt collectif, la Clinique Mutualiste propose aux patients une chirurgie et une médecine de haute qualité sans aucun dépassement d’honoraires."

During the past decade, BAYLOT Denis conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "BAYLOT Denis" #1 collaborator was "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "BAYLOT Denis" are "Major Orthopaedic Surgery and Renal Impairment" (1 trials) and "Orthopedic Surgery" (1 trials). Many other conditions were trialed in "BAYLOT Denis" in a lesser frequency.

Most popular intervention types in "BAYLOT Denis" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "fondaparinux 1.5 mg/day" (1 trials). Other intervention names were less common.

The vast majority of trials in "BAYLOT Denis" are 2 trials for "All" genders.

Currently, there are NaN active trials in "BAYLOT Denis". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in BAYLOT Denis, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in BAYLOT Denis, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".